Lucia Knopfová

861 citations
41 papers · 689 indexed · h-index 15
Topics
NF-κB Signaling Pathways (6 papers)Cancer Cells and Metastasis (5 papers)Immune cells in cancer (5 papers)
Journals
SHILAP Revista de lepidopterologíaAnalytical ChemistryCancer Research

In The Last Decade

Lucia Knopfová

36 papers receiving 678 citations

Peers

Lucia Knopfová
Comparison fields: 5 of 100
  • Molecular Biology 358
  • Oncology 190
  • Cancer Research 125
  • Immunology 100
  • Biomedical Engineering 72
Replace Heng Tang with:
Heng Tang China
Mihail Buse Romania
Qiong Li China
Gianluca Di Cara Italy
Dan Mao China
Zhiwen Fu China
Akiko Nakayama Japan
Fanni Li China
Mei Zhang China
Lucia Knopfová relative to Heng Tang China Heng Tang's profile →
Citations per field
00.5×1.5×2.5×
Heng Tang · 1×
Citations per year

Countries citing papers authored by Lucia Knopfová

Since Specialization
Citations

This map shows the geographic impact of Lucia Knopfová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucia Knopfová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucia Knopfová more than expected).

Fields of papers citing papers by Lucia Knopfová

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lucia Knopfová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucia Knopfová. The network helps show where Lucia Knopfová may publish in the future.

Co-authorship network of co-authors of Lucia Knopfová

This figure shows the co-authorship network connecting the top 25 collaborators of Lucia Knopfová. A scholar is included among the top collaborators of Lucia Knopfová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lucia Knopfová. Lucia Knopfová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 0
3 4
4 0
5 6
6 15
7 45
8 4
9 9
10 45
11 65
12 9
13 14
14 8
15 35
16 66
17 22
18
Inhibition of topoisomerase IIa: Novel function ofwedelolactone
1
19 57
20 24

About Lucia Knopfová

Lucia Knopfová is a scholar working on Cancer Research, Oncology and Immunology and Allergy, having authored 41 papers that have together received 689 indexed citations. Recurring topics across this work include NF-κB Signaling Pathways (6 papers), Cancer Cells and Metastasis (5 papers) and Immune cells in cancer (5 papers). The work is most often cited by research in Cancer Research (125 citations), Oncology (190 citations) and Complementary and alternative medicine (49 citations). Lucia Knopfová has collaborated with scholars based in Czechia, Switzerland and Ukraine. Frequent co-authors include Jan Šmarda, Petr Beneš, Karel Souček, Lubor Borsig, Michal Masařík, Markéta Hermanová, Marko Roblek, Stefan W. Schneider, Jaromír Gumulec and Vojtěch Adam. Their work appears in journals such as SHILAP Revista de lepidopterología, Analytical Chemistry and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026